TruScreen Group Limited (NZE: TRU)

Market Cap	10.50M
Revenue (ttm)	2.60M
Net Income (ttm)	-2.05M
Shares Out	552.59M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,975
Open	0.0210
Previous Close	0.0210
Day's Range	0.0210 - 0.0210
52-Week Range	0.0150 - 0.0293
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. T...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: TRU

Financial Performance

In 2023, TruScreen Group's revenue was 2.60 million, an increase of 25.18% compared to the previous year's 2.08 million. Losses were -2.05 million, -14.63% less than in 2022.